Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Accounts Payables: 2017-2023

Historic Accounts Payables for Solid Biosciences (SLDB) over the last 7 years, with Dec 2023 value amounting to $2.0 million.

  • Solid Biosciences' Accounts Payables rose 82.19% to $3.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.5 million, marking a year-over-year increase of 82.19%. This contributed to the annual value of $2.0 million for FY2023, which is 37.25% down from last year.
  • Per Solid Biosciences' latest filing, its Accounts Payables stood at $2.0 million for FY2023, which was down 37.25% from $3.2 million recorded in FY2022.
  • Over the past 5 years, Solid Biosciences' Accounts Payables peaked at $7.1 million during FY2019, and registered a low of $2.0 million during FY2023.
  • Its 3-year average for Accounts Payables is $3.2 million, with a median of $3.2 million in 2022.
  • As far as peak fluctuations go, Solid Biosciences' Accounts Payables spiked by 93.01% in 2019, and later slumped by 54.04% in 2020.
  • Yearly analysis of 5 years shows Solid Biosciences' Accounts Payables stood at $7.1 million in 2019, then tumbled by 54.04% to $3.3 million in 2020, then skyrocketed by 36.32% to $4.5 million in 2021, then fell by 27.45% to $3.2 million in 2022, then slumped by 37.25% to $2.0 million in 2023.